Comparison between Arunaya Organics IPO and GNH India Pharmaceuticals IPO.
Arunaya Organics IPO is a SME Bookbuilding IPO proposed to list at NSE SME while GNH India Pharmaceuticals IPO is a SME Bookbuilding proposed to list at NSE SME.
| Arunaya Organics IPO | GNH India Pharmaceuticals IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | NSE SME | NSE SME |
| Lead Managers | Unistone Capital Pvt.Ltd. | Gretex Corporate Services Ltd. |
| Registrar | Bigshare Services Pvt.Ltd. | Purva Sharegistry (India) Pvt.Ltd. |
| Market Maker | R.K.Stock Holding Pvt.Ltd. | Gretex Share Broking Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL |
The total issue size of Arunaya Organics IPO is up to ₹32.27 Cr whereas the issue size of the GNH India Pharmaceuticals IPO is up to ₹0.00 Cr. The final issue price of Arunaya Organics IPO is ₹58.00 per share and of GNH India Pharmaceuticals IPO is .
| Arunaya Organics IPO | GNH India Pharmaceuticals IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹55.00 per share | |
| Issue Price (Upper) | ₹58.00 per share | |
| Issue Price (Final) | ₹58.00 per share | |
| Discount (Retail) | ₹0.00 per share | |
| Discount (Employee) | ||
| Market Lot Size | 2000 shares | |
| Fresh Issue Size | 49,64,000 shares | 37,00,000 shares |
| Fresh Issue Size (Amount) | up to ₹28.79 Cr | up to ₹0.00 Cr |
| OFS Issue Size | 6,00,000 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹3.48 Cr | up to ₹0.00 Cr |
| Issue Size Total | 55,64,000 shares | 0 shares |
| Issue Size Total (Amount) | up to ₹32.27 Cr | up to ₹0.00 Cr |
Arunaya Organics IPO opens on Apr 29, 2025, while GNH India Pharmaceuticals IPO opens on . The closing date of Arunaya Organics IPO and GNH India Pharmaceuticals IPO is May 02, 2025, and , respectively.
| Arunaya Organics IPO | GNH India Pharmaceuticals IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Apr 29, 2025 | |
| Issue Close | May 02, 2025 | |
| Basis Of Allotment (Tentative) | May 05, 2025 | |
| Initiation of Refunds (Tentative) | May 06, 2025 | |
| Credit of Share (Tentative) | May 06, 2025 | |
| Listing date (Tentative) | May 07, 2025 | |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Arunaya Organics IPO P/E ratio is 17.55, as compared to GNH India Pharmaceuticals IPO P/E ratio of .
| Arunaya Organics IPO | GNH India Pharmaceuticals IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)
| Company Financials (Restated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 91.72 | 100 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 60.79 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 17.55 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹101.72 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 44.15% | 22.99% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 55.71% | 21.49% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 1.19 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹3.30 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 36.27% | 16.81% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Arunaya Organics IPO Retail Individual Investors (RII) are offered 22,26,000 shares while in GNH India Pharmaceuticals IPO retail investors are offered 22,26,000 shares. Qualified Institutional Buyers (QIB) are offered 11,12,000 shares in Arunaya Organics IPO and in GNH India Pharmaceuticals IPO.
| Arunaya Organics IPO | GNH India Pharmaceuticals IPO | |
|---|---|---|
| Anchor Investor Reservation | ||
| Market Maker Reservation | 2,96,000 shares | |
| QIB | 11,12,000 shares | |
| NII | 22,26,000 shares | |
| RII | 22,26,000 shares | |
| Employee | 0 shares | |
| Others | ||
| Total | 55,64,000 shares |
Arunaya Organics IPO subscribed 2.53x in total, whereas GNH India Pharmaceuticals IPO subscribed .
| Arunaya Organics IPO | GNH India Pharmaceuticals IPO | |
|---|---|---|
| QIB (times) | 1.01x | |
| NII (times) | 1.49x | |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 4.33x | |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 2.53x |
